ImmunoGen
IMGN
#2103
Rank
NZ$15.94 B
Marketcap
NZ$57.09
Share price
0.00%
Change (1 day)
139.30%
Change (1 year)

Earnings for ImmunoGen (IMGN)

Earnings in 2023 (TTM): -NZ$96.61 Million

According to ImmunoGen 's latest financial reports the company's current earnings are NZ$0.28 Billion. In 2022 the company made an earning of -NZ$0.4 Billion a decrease over its 2021 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoGen from 1989 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$96.61 Million-75.71%
2022 -NZ$0.4 Billion72.45%
2021 -NZ$0.24 Billion495.9%
2020 -NZ$38.7 Million-75.71%
2019 -NZ$0.16 Billion-44.88%
2018 -NZ$0.29 Billion99.42%
2017 -NZ$0.15 Billion
2015 -NZ$0.2 Billion43.7%
2014 -NZ$0.14 Billion135.39%
2013 -NZ$56.38 Million-66.03%
2012 -NZ$0.17 Billion42.86%
2011 -NZ$0.12 Billion16.68%
2010 -NZ$99.55 Million32.83%
2009 -NZ$74.95 Million-1.99%
2008 -NZ$76.47 Million108.61%
2007 -NZ$36.66 Million-10.13%
2006 -NZ$40.79 Million28.86%
2005 -NZ$31.66 Million120.33%
2004 -NZ$14.37 Million-61.19%
2003 -NZ$37.02 Million-16.6%
2002 -NZ$44.39 Million51.86%
2001 -NZ$29.23 Million
1999 NZ$1.64 M-112.68%
1998 -NZ$12.98 Million-13.41%
1997 -NZ$14.99 Million-10.87%
1996 -NZ$16.82 Million-35.66%
1995 -NZ$26.15 Million-19.21%
1994 -NZ$32.36 Million-14.49%
1993 -NZ$37.84 Million23.95%
1992 -NZ$30.53 Million
1989 -NZ$12.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-29,920.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$23.11 B-20,238.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.73 B-11,199.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.55 B-55,483.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.20 B-17,704.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$14.23 B-12,505.47%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$20.71 B-18,150.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.45 Billion 1,159.30%๐Ÿ‡บ๐Ÿ‡ธ USA